Authors:
TUTTLE TM
ANDERSON BW
THOMPSON WE
LEE JE
SAHIN A
SMITH TL
GRABSTEIN KH
WHARTON JT
IOANNIDES CG
MURRAY JL
Citation: Tm. Tuttle et al., PROLIFERATIVE AND CYTOKINE RESPONSES TO CLASS-II HER-2 NEU-ASSOCIATEDPEPTIDES IN BREAST-CANCER PATIENTS/, Clinical cancer research, 4(8), 1998, pp. 2015-2024
Authors:
CASTILLEJA A
OBRIAN CA
ANDERSON BW
WHARTON JT
IOANNIDES CG
Citation: A. Castilleja et al., INHIBITION OF CTL EPITOPE PRESENTATION AND TUMOR IMMUNOGENICITY BY HER-2 TYROSINE PHOSPHORYLATION, The FASEB journal, 12(4), 1998, pp. 1684-1684
Authors:
TUTTLE TM
THOMPSON WE
ANDERSON BW
LEE JE
GRABSTEIN KW
MURRAY JL
WHARTON JT
IOANNIDES CG
Citation: Tm. Tuttle et al., HER-2 NEU PEPTIDE INDUCES TH1 RESPONSES IN ASSOCIATION WITH HLA-DR4 IN BREAST-CANCER PATIENTS/, Journal of allergy and clinical immunology, 99(1), 1997, pp. 188-188
Authors:
FISK B
ANDERSON BW
GRAVITT KR
OBRIAN CA
KUDELKA AP
MURRAY JL
WHARTON JT
IOANNIDES CG
Citation: B. Fisk et al., IDENTIFICATION OF NATURALLY PROCESSED HUMAN OVARIAN PEPTIDES RECOGNIZED BY TUMOR-ASSOCIATED CD8(-LYMPHOCYTES() CYTOTOXIC T), Cancer research, 57(1), 1997, pp. 87-93